Alice Goodman

All articles by Alice Goodman

Oral Platinum Analogue Looks Good

NEW YORK—Satraplatin, the first oral platinum analogue, is among the more promising second-line treatments for hormone-refractory prostate cancer (HRPC), a researcher said here at the 2006 Chemotherapy Foundation Symposium.

High Pregnancy BP Increases Risk

CHICAGO—Hypertension that develops during pregnancy places women at higher risk for the condition when they get older, researchers reported at the American Heart Association 2006 Scientific Sessions.

Drug Is Beneficial In Some PCa Cases

NEW YORK CITY—Results of the largest clinical trial ever conducted in non-metastatic prostate cancer suggest that bicalutamide (Casodex) added to standard care may improve overall survival in men with locally advanced disease undergoing radiotherapy.

Post-MI Mortality Risk Linked to GFR

CHICAGO—Using plasma fasting glucose level and glomerular filtration rate (GFR) in conjunction with the TIMI risk index improves 30-day mortality predictions following acute MI, data show.

New Medication Improves PCa Outcomes

NEW YORK—A high-dose oral formulation of calcitriol, called DN 101 and used in combination with docetaxel, is associated with longer survival in men with hormone-refractory prostate cancer (HRPC), according to a recent study.

Immunotherapy-Chemo Combo Possible

NEW YORK—Immunotherapy with sipuleucel-T followed by docetaxel chemotherapy may prolong survival in patients with androgen-independent prostate cancer (AIPC), a researcher reported here at the Chemotherapy Foundation Symposium.

Next post in News